NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001900

Registered date:23/04/2009

PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic Myeloid Leukemia (chronic phase)
Date of first enrollment2009/04/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Dasatinib

Outcome(s)

Primary OutcomeMMR rate
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum15years-old
Age maximum99years-old
GenderMale and Female
Include criteria
Exclude criteriadouble cancer pregnancy etc

Related Information

Contact

public contact
Name
Address Uchimaru19-1,Morioka,Japan Japan
Telephone
E-mail
Affiliation Iwate Medical University hematology/oncology
scientific contact
Name Yoji Ishida
Address Uchimaru19-1,Moriaka,Japan Japan
Telephone
E-mail
Affiliation Iwate Medical Unversity, Internal Medicine hematology/oncology